Endocrinology, Vol 128, 857-862, Copyright © 1991 by Endocrine Society

ARTICLES

Binding and action of insulin-like growth factor I in pituitary tumor cells

H Yamasaki, D Prager, S Gebremedhin, L Moise and S Melmed
Department of Medicine, Cedars-Sinai Medical Center-UCLA School of Medicine 90048.

Insulin-like growth factor I (IGF-I), a target hormone mediating most of the growth effects of GH, suppresses GH gene expression in a feedback regulatory loop, which may be either endocrine or paracrine in nature. Although IGF-I has been shown to directly attenuate GH gene transcription, the relationship of IGF-I binding and action in the somatotroph cell remains unclear. Therefore, IGF-I binding and action were compared in two different pituitary cell lines both secreting GH. Recombinant human IGF-I attenuated GH secretion in GC cells by up to 70% after 48 h in a dose-dependent manner. Surprisingly, IGF-I failed to suppress GH secretion in GH3 cells, a clonally related pituitary cell line. Binding studies showed that although the KD for IGF-I was similar in both cell types, GC cells contain 3-fold more IGF-I binding sites compared to GH3 cells, possibly explaining their resistance to IGF-I action. Nevertheless, both cell lines possessed abundant and similar binding sites for insulin. These results imply that the IGF-I signal for GH gene regulation is receptor-mediated and directly correlated with the number of pituitary IGF-I binding sites. Availability of pituitary IGF-I binding sites may therefore be important in determining the level of GH expression by the somatotroph.

This article has been cited by other articles:

				C. R. Croutch, M. Lebofsky, K.-W. Schramm, P. F. Terranova, and K. K. Rozman 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) and 1,2,3,4,7,8-Hexachlorodibenzo-p-Dioxin (HxCDD) Alter Body Weight by Decreasing Insulin-Like Growth Factor I (IGF-I) Signaling Toxicol. Sci., May 1, 2005; 85(1): 560 - 571. [Abstract] [Full Text] [PDF]

				S. Fruchtman, D. C. McVey, and R. J. Borski Characterization of pituitary IGF-I receptors: modulation of prolactin and growth hormone Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2002; 283(2): R468 - R476. [Abstract] [Full Text] [PDF]

				C. A. Jaffe, W. Pan, M. B. Brown, R. DeMott-Friberg, and A. L. Barkan Regulation of GH Secretion in Acromegaly: Reproducibility of Daily GH Profiles and Attenuated Negative Feedback by IGF-I J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4364 - 4370. [Abstract] [Full Text] [PDF]

				S. Fruchtman, L. Jackson, and R. Borski Insulin-Like Growth Factor I Disparately Regulates Prolactin and Growth Hormone Synthesis and Secretion: Studies Using the Teleost Pituitary Model Endocrinology, August 1, 2000; 141(8): 2886 - 2894. [Abstract] [Full Text] [PDF]

				L. Stefaneanu, L. Powell-Braxton, W. Won, V. Chandrashekar, and A. Bartke Somatotroph and Lactotroph Changes in the Adenohypophyses of Mice with Disrupted Insulin-Like Growth Factor I Gene Endocrinology, September 1, 1999; 140(9): 3881 - 3889. [Abstract] [Full Text]

				A. Niiori-Onishi, Y. Iwasaki, N. Mutsuga, Y. Oiso, K. Inoue, and H. Saito Molecular Mechanisms of the Negative Effect of Insulin-Like Growth Factor-I on Growth Hormone Gene Expression in MtT/S Somatotroph Cells Endocrinology, January 1, 1999; 140(1): 344 - 349. [Abstract] [Full Text]

				A. I. Castillo and A. Aranda Differential Regulation of Pituitary-Specific Gene Expression by Insulin-Like Growth Factor 1 in Rat Pituitary GH4C1 and GH3 Cells Endocrinology, December 1, 1997; 138(12): 5442 - 5451. [Abstract] [Full Text] [PDF]

				D. Ray and S. Melmed Pituitary Cytokine and Growth Factor Expression and Action Endocr. Rev., April 1, 1997; 18(2): 206 - 228. [Abstract] [Full Text]